Annual Total Liabilities
$28.82 M
+$6.64 M+29.96%
30 April 2024
Summary:
KalVista Pharmaceuticals annual total liabilities is currently $28.82 million, with the most recent change of +$6.64 million (+29.96%) on 30 April 2024. During the last 3 years, it has risen by +$14.00 million (+94.48%). KALV annual total liabilities is now -43.29% below its all-time high of $50.83 million, reached on 31 December 2014.KALV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$27.40 M
-$1.42 M-4.94%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly total liabilities is currently $27.40 million, with the most recent change of -$1.42 million (-4.94%) on 31 July 2024. Over the past year, it has increased by +$3.10 million (+12.77%). KALV quarterly total liabilities is now -51.66% below its all-time high of $56.68 million, reached on 31 March 2015.KALV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.0% | +12.8% |
| 3 y3 years | +94.5% | +67.7% |
| 5 y5 years | +34.7% | +91.9% |
KALV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +94.5% | -4.9% | +67.7% |
| 5 y | 5 years | at high | +228.4% | -4.9% | +258.6% |
| alltime | all time | -43.3% | +855.0% | -51.7% | +1322.6% |
KalVista Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $27.40 M(-4.9%) |
| Apr 2024 | $28.82 M(+30.0%) | $28.82 M(+13.5%) |
| Jan 2024 | - | $25.39 M(+4.5%) |
| Oct 2023 | - | $24.30 M(+15.7%) |
| July 2023 | - | $21.00 M(-5.3%) |
| Apr 2023 | $22.18 M(+18.0%) | $22.18 M(+16.6%) |
| Jan 2023 | - | $19.03 M(+0.0%) |
| Oct 2022 | - | $19.02 M(+7.2%) |
| July 2022 | - | $17.75 M(-5.5%) |
| Apr 2022 | - | $18.79 M(+9.8%) |
| Apr 2022 | $18.79 M(+26.8%) | - |
| Jan 2022 | - | $17.12 M(+4.8%) |
| Oct 2021 | - | $16.34 M(+11.1%) |
| July 2021 | - | $14.70 M(-0.8%) |
| Apr 2021 | $14.82 M(+68.9%) | $14.82 M(+94.0%) |
| Jan 2021 | - | $7.64 M(-27.0%) |
| Oct 2020 | - | $10.47 M(+10.6%) |
| July 2020 | - | $9.47 M(+7.9%) |
| Apr 2020 | $8.78 M(-59.0%) | $8.78 M(-33.4%) |
| Jan 2020 | - | $13.19 M(-7.6%) |
| Oct 2019 | - | $14.28 M(-20.8%) |
| July 2019 | - | $18.02 M(-15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | $21.39 M(-37.3%) | $21.39 M(-4.9%) |
| Jan 2019 | - | $22.49 M(-12.2%) |
| Oct 2018 | - | $25.61 M(-18.4%) |
| July 2018 | - | $31.37 M(-8.1%) |
| Apr 2018 | $34.14 M(+1031.1%) | $34.14 M(-10.4%) |
| Jan 2018 | - | $38.09 M(+940.1%) |
| Oct 2017 | - | $3.66 M(-9.6%) |
| July 2017 | - | $4.05 M(+34.2%) |
| Apr 2017 | $3.02 M(-7.1%) | $3.02 M(-5.7%) |
| Jan 2017 | - | $3.20 M(+66.2%) |
| Sept 2016 | - | $1.93 M(-2.3%) |
| June 2016 | - | $1.97 M(-70.2%) |
| Apr 2016 | $3.25 M(-56.6%) | - |
| Mar 2016 | - | $6.60 M(-11.7%) |
| Dec 2015 | $7.48 M(-85.3%) | $7.48 M(+0.3%) |
| Sept 2015 | - | $7.46 M(-9.9%) |
| June 2015 | - | $8.27 M(-85.4%) |
| Mar 2015 | - | $56.68 M(+11.5%) |
| Dec 2014 | $50.83 M(+16.0%) | $50.83 M(+0.6%) |
| Sept 2014 | - | $50.50 M(+15.3%) |
| Dec 2013 | $43.81 M(+19.0%) | $43.81 M |
| Dec 2012 | $36.81 M | - |
FAQ
- What is KalVista Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual total liabilities year-on-year change?
- What is KalVista Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly total liabilities year-on-year change?
What is KalVista Pharmaceuticals annual total liabilities?
The current annual total liabilities of KALV is $28.82 M
What is the all time high annual total liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total liabilities is $50.83 M
What is KalVista Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, KALV annual total liabilities has changed by +$6.64 M (+29.96%)
What is KalVista Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of KALV is $27.40 M
What is the all time high quarterly total liabilities for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total liabilities is $56.68 M
What is KalVista Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, KALV quarterly total liabilities has changed by +$3.10 M (+12.77%)